Investment Summary

Nordic Capital Invests In Brightpoint

On January 1, 2006, private equity firm Nordic Capital invested in distribution company Brightpoint

Investment Highlights
  • This is Nordic Capital’s 4th transaction in the Distribution sector.
  • This is Nordic Capital’s 2nd transaction in the United States.
  • This is Nordic Capital’s 1st transaction in Indiana.
Investment Fate
  • Brightpoint went public in 2007.
  • Brightpoint was sold to a strategic buyer in 2012 for 840M USD.

Investment Summary

Date 2006-01-01
Target Brightpoint
Sector Distribution
Investor(s) Nordic Capital
Deal Type Stake Purchase

Target

Brightpoint

Indianapolis, Indiana, United States
BrightPoint provides a suite of end-to-end supply chain and customization solutions to manufacturers, retailers and carriers in the wireless device industry.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Nordic Capital

Stockholm, Sweden

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1989
PE ASSETS 31.0B EUR
Size Mega
Type Sector Agnostic
DESCRIPTION

Nordic Capital is a private equity investment firm that targets mid to large-sized company investments located in Northern Europe as well as the US. Nordic seeks investments across a wide range of industries and prefers situations where there are 'opportunities for new industrial combinations, strategic repositioning, international expansion and operational improvements'. Nordic Capital was formed in 1989 and is based in Stockholm, Sweden.


DEAL STATS #
Overall 43 of 142
Sector: Distribution M&A 4 of 5
Type: Stake Purchase M&A Deals 1 of 5
State: Indiana M&A 1 of 1
Country: United States M&A 2 of 16
Year: 2006 M&A 4 of 5
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-01-01 Fougera Pharmaceuticals

Melville, New York, United States

Fougera Pharmaceuticals Inc. operates two primary divisions in the US focused on specialty pharmaceuticals in dermatology: Fougera, its generic dermatology medicines business, and PharmaDerm, its branded dermatology business. Founded in 1849, the Fougera division is the leading manufacturer and distributor of a wide range of topical products. The PharmaDerm division is dedicated to developing and commercializing novel prescription products to treat diseases and conditions of the skin – the largest organ of the human body.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2006-03-16 Guide Konsult AB

Stockholm, Sweden

Guide Konsult provides IT consulting services for the car industry, pharmaceuticals, the public sector, the bank and finance industry and commerce.

Sell kr658M